Hook
Posted Oct 28, 2026Video · 0:24by @abcnews
We didn’t find a product being promoted in this video. Its hook, format and structure below still show why it took off.
Browse products winning on TikTokThe video leverages a high-interest, timely news topic regarding popular weight loss medications, providing clear, data-driven comparisons that satisfy viewer curiosity about medical advancements.
ABC News reports on clinical trial results comparing the weight loss drug Retatrutide to Ozempic. The report highlights that Retatrutide showed significantly higher weight loss and improved diabetes markers in a study conducted by Eli Lilly.
Eli Lilly says its experimental drug retatrutide delivered more than double the weight loss of Ozempic’s highest dose in a clinical trial and improved diabetes markers, cholesterol and blood pressure.
Pharmaceutical company Eli Lilly says its weight loss drug known as Retatrutide has revealed promising results over rival drugs such as Ozempic.
Introduction of Retatrutide and Eli Lilly
Comparison of weight loss results against Ozempic
Mention of additional health benefits
Announcement of upcoming FDA submission
Retatrutide (a) acts as the subject of the news report, with its clinical trial results being compared to Ozempic. Ozempic (a) acts as the comparative benchmark in the clinical trial results presented. Eli Lilly (a) acts as the pharmaceutical company reporting the trial results. ABC News (b) appears as the news outlet watermark and channel branding.

Promotes 5 products. Create free account to see more.
Outliers and viral hits: their videos on Overshot, all time.